However, more recent inhibitors have been discovered through various means, which not only reduced TGM-2 but also other factors such as MMP9, TIMP1 and 2; TNF-α and β, which increases cancer cells’ susceptibility to chemotherapy and inflammation [56,57,58,59,60,61]. This evidence concerns the gene TGM2 and cancer.